These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 22037042

  • 1. Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model.
    Chagniel L, Robitaille C, Lebel M, Cyr M.
    Neurobiol Dis; 2012 Jan; 45(1):645-55. PubMed ID: 22037042
    [Abstract] [Full Text] [Related]

  • 2. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Henry B, Crossman AR, Brotchie JM.
    Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768
    [Abstract] [Full Text] [Related]

  • 3. The involvement of RGS9 in l-3,4-dihydroxyphenylalanine-induced dyskinesias in unilateral 6-OHDA lesion rat model.
    Yin LL, Geng XC, Zhu XZ.
    Brain Res Bull; 2011 Nov 25; 86(5-6):367-72. PubMed ID: 21963945
    [Abstract] [Full Text] [Related]

  • 4. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Francardo V, Recchia A, Popovic N, Andersson D, Nissbrandt H, Cenci MA.
    Neurobiol Dis; 2011 Jun 25; 42(3):327-40. PubMed ID: 21310234
    [Abstract] [Full Text] [Related]

  • 5. RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease.
    Ko WK, Martin-Negrier ML, Bezard E, Crossman AR, Ravenscroft P.
    Neurobiol Dis; 2014 Oct 25; 70():138-48. PubMed ID: 24969021
    [Abstract] [Full Text] [Related]

  • 6. Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat.
    Lebel M, Chagniel L, Bureau G, Cyr M.
    Neurobiol Dis; 2010 Apr 25; 38(1):59-67. PubMed ID: 20060905
    [Abstract] [Full Text] [Related]

  • 7. Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats.
    Conti MM, Ostock CY, Lindenbach D, Goldenberg AA, Kampton E, Dell'isola R, Katzman AC, Bishop C.
    Neuropharmacology; 2014 Feb 25; 77():1-8. PubMed ID: 24067924
    [Abstract] [Full Text] [Related]

  • 8. Effect of cdk5 antagonist on L-dopa-induced dyskinesias in a rat model of Parkinson's disease.
    Guan Q, Liu X, He Y, Jin L, Zhao L.
    Int J Neurosci; 2010 Jun 25; 120(6):421-7. PubMed ID: 20504213
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nociceptive Response to L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats.
    Nascimento GC, Bariotto-Dos-Santos K, Leite-Panissi CRA, Del-Bel EA, Bortolanza M.
    Neurotox Res; 2018 Nov 25; 34(4):799-807. PubMed ID: 29611150
    [Abstract] [Full Text] [Related]

  • 16. 5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model.
    Tronci E, Lisci C, Stancampiano R, Fidalgo C, Collu M, Devoto P, Carta M.
    Neurobiol Dis; 2013 Dec 25; 60():108-14. PubMed ID: 24004632
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The combination of lithium and l-Dopa/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson׳s disease therapy.
    Lazzara CA, Riley RR, Rane A, Andersen JK, Kim YH.
    Brain Res; 2015 Oct 05; 1622():127-36. PubMed ID: 26119916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.